---
http_interactions:
- request:
    method: get
    uri: https://www.googleapis.com/customsearch/v1?alt=json&cx=***REMOVED***&key=***REMOVED***&lr=lang_en&q=electro%20coagulation%20site:usa.gov&quotaUser=USASearch&safe=medium
    body:
      encoding: US-ASCII
      string: ''
    headers:
      User-Agent:
      - USASearch
      Accept-Encoding:
      - gzip;q=1.0,deflate;q=0.6,identity;q=0.3
      Accept:
      - "*/*"
      Connection:
      - keep-alive
      Keep-Alive:
      - 30
  response:
    status:
      code: 200
      message: OK
    headers:
      Expires:
      - Mon, 27 Nov 2017 17:51:15 GMT
      Date:
      - Mon, 27 Nov 2017 17:51:15 GMT
      Cache-Control:
      - private, max-age=0, must-revalidate, no-transform
      Etag:
      - '"5Zlg0hddrJE62d4cVfAnWQWbWFk/_o2O4YdWQ9U0V2FXn3ZAHArXrLc"'
      Vary:
      - Origin
      - X-Origin
      Content-Type:
      - application/json; charset=UTF-8
      X-Content-Type-Options:
      - nosniff
      X-Frame-Options:
      - SAMEORIGIN
      X-Xss-Protection:
      - 1; mode=block
      Server:
      - GSE
      Alt-Svc:
      - hq=":443"; ma=2592000; quic=51303431; quic=51303339; quic=51303338; quic=51303337;
        quic=51303335,quic=":443"; ma=2592000; v="41,39,38,37,35"
      Transfer-Encoding:
      - chunked
    body:
      encoding: UTF-8
      string: |
        {
         "kind": "customsearch#search",
         "url": {
          "type": "application/json",
          "template": "https://www.googleapis.com/customsearch/v1?q={searchTerms}&num={count?}&start={startIndex?}&lr={language?}&safe={safe?}&cx={cx?}&sort={sort?}&filter={filter?}&gl={gl?}&cr={cr?}&googlehost={googleHost?}&c2coff={disableCnTwTranslation?}&hq={hq?}&hl={hl?}&siteSearch={siteSearch?}&siteSearchFilter={siteSearchFilter?}&exactTerms={exactTerms?}&excludeTerms={excludeTerms?}&linkSite={linkSite?}&orTerms={orTerms?}&relatedSite={relatedSite?}&dateRestrict={dateRestrict?}&lowRange={lowRange?}&highRange={highRange?}&searchType={searchType}&fileType={fileType?}&rights={rights?}&imgSize={imgSize?}&imgType={imgType?}&imgColorType={imgColorType?}&imgDominantColor={imgDominantColor?}&alt=json"
         },
         "queries": {
          "request": [
           {
            "title": "Google Custom Search - electro coagulation site:usa.gov",
            "totalResults": "6",
            "searchTerms": "electro coagulation site:usa.gov",
            "count": 6,
            "startIndex": 1,
            "language": "lang_en",
            "inputEncoding": "utf8",
            "outputEncoding": "utf8",
            "safe": "medium",
            "cx": "***REMOVED***"
           }
          ]
         },
         "context": {
          "title": "DigitalGov Search 2017"
         },
         "searchInformation": {
          "searchTime": 0.176827,
          "formattedSearchTime": "0.18",
          "totalResults": "6",
          "formattedTotalResults": "6"
         },
         "spelling": {
          "correctedQuery": "electrocoagulation site:usa.gov",
          "htmlCorrectedQuery": "\u003cb\u003e\u003ci\u003eelectrocoagulation\u003c/i\u003e\u003c/b\u003e site:usa.gov"
         },
         "items": [
          {
           "kind": "customsearch#result",
           "title": "Esophageal Cancer Treatment (PDQ®)—Patient Version - National ...",
           "htmlTitle": "Esophageal Cancer Treatment (PDQ®)—Patient Version - National ...",
           "link": "http://1.usa.gov/11Wqk3m",
           "displayLink": "1.usa.gov",
           "snippet": "Jul 19, 2016 ... There are different types of treatment for patients with esophageal cancer. \nPatients have special nutritional needs during treatment for esophageal cancer. \nSix types of standard treatment are used: Surgery; Radiation therapy; \nChemotherapy; Chemoradiation therapy; Laser therapy; Electrocoagulation.",
           "htmlSnippet": "Jul 19, 2016 \u003cb\u003e...\u003c/b\u003e There are different types of treatment for patients with esophageal cancer. \u003cbr\u003e\nPatients have special nutritional needs during treatment for esophageal cancer. \u003cbr\u003e\nSix types of standard treatment are used: Surgery; Radiation therapy; \u003cbr\u003e\nChemotherapy; Chemoradiation therapy; Laser therapy; \u003cb\u003eElectrocoagulation\u003c/b\u003e.",
           "cacheId": "U4ENvs7WbFkJ",
           "formattedUrl": "1.usa.gov/11Wqk3m",
           "htmlFormattedUrl": "1.usa.gov/11Wqk3m",
           "pagemap": {
            "cse_thumbnail": [
             {
              "width": "192",
              "height": "262",
              "src": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR4FZ8aIe_VFhpYjySOuZrWbfYGzHkUxNfpfPWv10pnrTS9jCTpp42jcXY3"
             }
            ],
            "metatags": [
             {
              "viewport": "width=device-width, user-scalable=no, initial-scale=1, maximum-scale=1, minimum-scale=1, shrink-to-fit=no",
              "apple-mobile-web-app-title": "Cancer.gov",
              "application-name": "Cancer.gov",
              "msapplication-config": "/publishedcontent/images/images/design-elements/icons/favicons/browserconfig.xml?v=oLa52veKe8",
              "theme-color": "#ffffff",
              "content-language": "en",
              "english-linking-policy": "/policies/linking",
              "espanol-linking-policy": "/espanol/politicas/enlaces",
              "dcterms.type": "pdqCancerInfoSummary",
              "og:title": "Esophageal Cancer Treatment",
              "og:description": "Expert-reviewed information summary about the treatment of esophageal cancer.",
              "og:type": "Website",
              "og:site_name": "National Cancer Institute",
              "og:url": "https://www.cancer.gov/types/esophageal/patient/esophageal-treatment-pdq",
              "twitter:card": "summary"
             }
            ],
            "cse_image": [
             {
              "src": "https://www.cancer.gov/images/cdr/live/CDR428446-750.jpg"
             }
            ]
           }
          },
          {
           "kind": "customsearch#result",
           "title": "Home | Blood Disorders | NCBDDD | CDC",
           "htmlTitle": "Home | Blood Disorders | NCBDDD | CDC",
           "link": "http://1.usa.gov/1iyMIR6",
           "displayLink": "1.usa.gov",
           "snippet": "Jul 18, 2017 ... The Centers for Disease Control and Prevention (CDC) is working toward \ndeveloping a comprehensive public health agenda to promote and improve the \nhealth of people with blood disorders.",
           "htmlSnippet": "Jul 18, 2017 \u003cb\u003e...\u003c/b\u003e The Centers for Disease Control and Prevention (CDC) is working toward \u003cbr\u003e\ndeveloping a comprehensive public health agenda to promote and improve the \u003cbr\u003e\nhealth of people with blood disorders.",
           "cacheId": "K8ywXwzwv2EJ",
           "formattedUrl": "1.usa.gov/1iyMIR6",
           "htmlFormattedUrl": "1.usa.gov/1iyMIR6",
           "pagemap": {
            "cse_thumbnail": [
             {
              "width": "318",
              "height": "159",
              "src": "https://encrypted-tbn1.gstatic.com/images?q=tbn:ANd9GcSi9LOIMN8NG2ATxxUwqEumwEz7O33N0Ou3aGEWvVMbBzEpsnGBYl8AU7A"
             }
            ],
            "organization": [
             {
              "url": "Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention"
             },
             {
              "telephone": "800-CDC-INFO (800-232-4636)"
             }
            ],
            "postaladdress": [
             {
              "streetaddress": "1600 Clifton Road",
              "addresslocality": "Atlanta",
              "addressregion": "GA",
              "postalcode": "30329-4027",
              "addresscountry": "USA"
             }
            ],
            "contactpoint": [
             {
              "url": "Email CDC-INFO"
             },
             {
              "url": "U.S. Department of Health & Human Services"
             },
             {
              "url": "HHS/Open"
             },
             {
              "url": "USA.gov"
             }
            ],
            "metatags": [
             {
              "viewport": "width=device-width, initial-scale=1",
              "og:title": "Home | Blood Disorders | NCBDDD | CDC",
              "og:description": "Read information about various blood disorders.",
              "fb:app_id": "205691699516606",
              "og:url": "https://www.cdc.gov/ncbddd/blooddisorders/index.html",
              "og:image": "https://www.cdc.gov/ncbddd/hemophilia/sm/sm-bleeding-disorders-600x300.jpg",
              "og:image:type": "image/jpeg",
              "article:published_time": "2017-07-18",
              "og:author": "CDC",
              "article:author": "CDC",
              "og:site_name": "Centers for Disease Control and Prevention",
              "og:type": "article",
              "twitter:card": "summary_large_image",
              "twitter:site": "@CDCgov",
              "twitter:creator": "@CDCgov",
              "twitter:title": "Home | Blood Disorders | NCBDDD | CDC",
              "twitter:description": "Read information about various blood disorders.",
              "twitter:domain": "https://go.usa.gov/xncdP",
              "twitter:image:src": "https://www.cdc.gov/ncbddd/hemophilia/sm/sm-bleeding-disorders-600x300.jpg",
              "cdc:template_version": "3.0",
              "cdc:content_id": "25669",
              "cdc:wcms_build": "4.4.1 - b.22",
              "application-name": "CDC.gov",
              "msapplication-tilecolor": "#0061aa",
              "msapplication-square70x70logo": "/TemplatePackage/3.0/images/Win8_tile_70x70.png",
              "msapplication-square150x150logo": "/TemplatePackage/3.0/images/Win8_tile_150x150.png",
              "msapplication-wide310x150logo": "/TemplatePackage/3.0/images/Win8_tile_310x150.png",
              "msapplication-square310x310logo": "/TemplatePackage/3.0/images/Win8_tile_310x310.png",
              "dc.date": "2017-10-05T08:18:53Z"
             }
            ],
            "webpage": [
             {
              "lastreviewed": "July 18, 2017",
              "datemodified": "July 18, 2017"
             }
            ],
            "cse_image": [
             {
              "src": "https://www.cdc.gov/ncbddd/hemophilia/sm/sm-bleeding-disorders-600x300.jpg"
             }
            ]
           }
          },
          {
           "kind": "customsearch#result",
           "title": "Anogenital Warts - 2015 STD Treatment Guidelines",
           "htmlTitle": "Anogenital Warts - 2015 STD Treatment Guidelines",
           "link": "https://go.usa.gov/xZWnR",
           "displayLink": "go.usa.gov",
           "snippet": "Jun 4, 2015 ... ... ventilation (e.g., a smoke evacuator) (777(https://www.cdc.gov/std/tg2015/\nreferences.htm#777)) (https://www.cdc.gov/niosh/docs/hazardcontrol/hc11.html). \nTrichloroacetic acid (TCA) and bichloroacetic acid (BCA) are provider-applied \ncaustic agents that destroy warts by chemical coagulation of proteins.",
           "htmlSnippet": "Jun 4, 2015 \u003cb\u003e...\u003c/b\u003e ... ventilation (e.g., a smoke evacuator) (777(https://www.cdc.gov/std/tg2015/\u003cbr\u003e\nreferences.htm#777)) (https://www.cdc.gov/niosh/docs/hazardcontrol/hc11.html). \u003cbr\u003e\nTrichloroacetic acid (TCA) and bichloroacetic acid (BCA) are provider-applied \u003cbr\u003e\ncaustic agents that destroy warts by chemical \u003cb\u003ecoagulation\u003c/b\u003e of proteins.",
           "cacheId": "Y7_twHPDOMIJ",
           "formattedUrl": "https://go.usa.gov/xZWnR",
           "htmlFormattedUrl": "https://go.usa.gov/xZWnR",
           "pagemap": {
            "organization": [
             {
              "url": "Division of STD Prevention"
             },
             {
              "telephone": "800-CDC-INFO (800-232-4636)"
             }
            ],
            "postaladdress": [
             {
              "streetaddress": "1600 Clifton Road",
              "addresslocality": "Atlanta",
              "addressregion": "GA",
              "postalcode": "30329-4027",
              "addresscountry": "USA"
             }
            ],
            "contactpoint": [
             {
              "url": "Email CDC-INFO"
             },
             {
              "url": "U.S. Department of Health & Human Services"
             },
             {
              "url": "HHS/Open"
             },
             {
              "url": "USA.gov"
             }
            ],
            "metatags": [
             {
              "viewport": "width=device-width, initial-scale=1",
              "cdc:template_version": "3.0",
              "cdc:content-id": "710499",
              "cdc:revision-id": "2",
              "application-name": "CDC.gov",
              "msapplication-tilecolor": "#0061aa",
              "msapplication-square70x70logo": "/TemplatePackage/3.0/images/Win8_tile_70x70.png",
              "msapplication-square150x150logo": "/TemplatePackage/3.0/images/Win8_tile_150x150.png",
              "msapplication-wide310x150logo": "/TemplatePackage/3.0/images/Win8_tile_310x150.png",
              "msapplication-square310x310logo": "/TemplatePackage/3.0/images/Win8_tile_310x310.png"
             }
            ],
            "webpage": [
             {
              "lastreviewed": "June 4, 2015",
              "datemodified": "June 4, 2015"
             }
            ]
           }
          },
          {
           "kind": "customsearch#result",
           "title": "PRAXBIND (idarucizumab) injection, for intravenous use",
           "htmlTitle": "PRAXBIND (idarucizumab) injection, for intravenous use",
           "link": "http://1.usa.gov/1QL4TG7",
           "displayLink": "1.usa.gov",
           "snippet": "coagulation parameters and reappearance of clinically relevant bleeding ... This \nindication is approved under accelerated approval based on a reduction in \nunbound dabigatran and normalization of coagulation parameters in healthy .... \nUsing an electro-chemiluminescence (ECL) based assay, plasma samples from \n283.",
           "htmlSnippet": "\u003cb\u003ecoagulation\u003c/b\u003e parameters and reappearance of clinically relevant bleeding ... This \u003cbr\u003e\nindication is approved under accelerated approval based on a reduction in \u003cbr\u003e\nunbound dabigatran and normalization of \u003cb\u003ecoagulation\u003c/b\u003e parameters in healthy .... \u003cbr\u003e\nUsing an \u003cb\u003eelectro\u003c/b\u003e-chemiluminescence (ECL) based assay, plasma samples from \u003cbr\u003e\n283.",
           "cacheId": "LC7egxIRtAQJ",
           "mime": "application/pdf",
           "fileFormat": "PDF/Adobe Acrobat",
           "formattedUrl": "1.usa.gov/1QL4TG7",
           "htmlFormattedUrl": "1.usa.gov/1QL4TG7",
           "pagemap": {
            "metatags": [
             {
              "author": "FDA",
              "creationdate": "D:20151016131421-04'00'",
              "moddate": "D:20151016131644-04'00'",
              "producer": "iText 2.1.7 by 1T3XT",
              "title": "PRAXBIND (idarucizumab) injection, for intravenous use"
             }
            ]
           }
          },
          {
           "kind": "customsearch#result",
           "title": "Esophageal Cancer Treatment (PDQ®)—Health Professional ...",
           "htmlTitle": "Esophageal Cancer Treatment (PDQ®)—Health Professional ...",
           "link": "http://1.usa.gov/UgWNer",
           "displayLink": "1.usa.gov",
           "snippet": "Feb 2, 2017 ... Nd:YAG endoluminal tumor destruction or electrocoagulation. Endoscopic-\nplaced stents to provide palliation of dysphagia. Radiation therapy with or without \nintraluminal intubation and dilation. Intraluminal brachytherapy to provide \npalliation of dysphagia. Recurrent Esophageal Cancer, Palliative use of any ...",
           "htmlSnippet": "Feb 2, 2017 \u003cb\u003e...\u003c/b\u003e Nd:YAG endoluminal tumor destruction or \u003cb\u003eelectrocoagulation\u003c/b\u003e. Endoscopic-\u003cbr\u003e\nplaced stents to provide palliation of dysphagia. Radiation therapy with or without \u003cbr\u003e\nintraluminal intubation and dilation. Intraluminal brachytherapy to provide \u003cbr\u003e\npalliation of dysphagia. Recurrent Esophageal Cancer, Palliative use of any&nbsp;...",
           "cacheId": "95bFTep_OSgJ",
           "formattedUrl": "1.usa.gov/UgWNer",
           "htmlFormattedUrl": "1.usa.gov/UgWNer",
           "pagemap": {
            "cse_thumbnail": [
             {
              "width": "192",
              "height": "262",
              "src": "https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcR4FZ8aIe_VFhpYjySOuZrWbfYGzHkUxNfpfPWv10pnrTS9jCTpp42jcXY3"
             }
            ],
            "metatags": [
             {
              "viewport": "width=device-width, user-scalable=no, initial-scale=1, maximum-scale=1, minimum-scale=1, shrink-to-fit=no",
              "apple-mobile-web-app-title": "Cancer.gov",
              "application-name": "Cancer.gov",
              "msapplication-config": "/publishedcontent/images/images/design-elements/icons/favicons/browserconfig.xml?v=oLa52veKe8",
              "theme-color": "#ffffff",
              "content-language": "en",
              "english-linking-policy": "/policies/linking",
              "espanol-linking-policy": "/espanol/politicas/enlaces",
              "dcterms.type": "pdqCancerInfoSummary",
              "og:title": "Esophageal Cancer Treatment",
              "og:description": "Expert-reviewed information summary about the treatment of esophageal cancer.",
              "og:type": "Website",
              "og:site_name": "National Cancer Institute",
              "og:url": "https://www.cancer.gov/types/esophageal/hp/esophageal-treatment-pdq",
              "twitter:card": "summary"
             }
            ],
            "cse_image": [
             {
              "src": "https://www.cancer.gov/images/cdr/live/CDR428446-750.jpg"
             }
            ]
           }
          },
          {
           "kind": "customsearch#result",
           "title": "Import Alert 89-08",
           "htmlTitle": "Import Alert 89-08",
           "link": "http://1.usa.gov/ZBU1iV",
           "displayLink": "1.usa.gov",
           "snippet": "NOTE: The revision of this Import Alert dated 09/28/2017, Updates the  \nGuidance  section. Changes are bracketed by asterisks (***). Note: Foreign firms \npreviously subject to detention without physical examination under Import Alert #\n73-03 are now listed on this alert. FDA believes these devices are Class 3 and \nneed a ...",
           "htmlSnippet": "NOTE: The revision of this Import Alert dated 09/28/2017, Updates the  \u003cbr\u003e\nGuidance  section. Changes are bracketed by asterisks (***). Note: Foreign firms \u003cbr\u003e\npreviously subject to detention without physical examination under Import Alert #\u003cbr\u003e\n73-03 are now listed on this alert. FDA believes these devices are Class 3 and \u003cbr\u003e\nneed a&nbsp;...",
           "formattedUrl": "1.usa.gov/ZBU1iV",
           "htmlFormattedUrl": "1.usa.gov/ZBU1iV",
           "pagemap": {
            "metatags": [
             {
              "dc.title": "Import Alert 89-08",
              "viewport": "width=device-width, initial-scale=1.0",
              "apple-mobile-web-app-title": "FDA",
              "apple-mobile-web-app-capable": "yes"
             }
            ]
           }
          }
         ]
        }
    http_version: 
  recorded_at: Mon, 27 Nov 2017 17:51:15 GMT
recorded_with: VCR 3.0.3
